Goldzieher J, et al: A cross sectional study of plasma FSH and LH levels in women using sequential, combination, or injectable steroid contraceptives over long periods of time . Contraception 2:225-248, 1970;.
AMA Department of Drugs: AMA Drug Evaluations , ed 2. Acton, Mass, Publishing Sciences Group, Inc, 1973;, pp 411-433.
Craft I, Peters T: Quantitative changes in plasma amino acids induced by oral contraceptives . Clin Sci 41:301-307, 1971;.
Honger PE, Rossing N: Albumin metabolism and oral contraception . Clin Sci 36:41-45, 1969;.
Barbosa J, Seal US, Doe RP: Effects of anabolic steroids on haptoglobin, orosomucoid, plasminogen, fibrinogen, transferrin, ceruloplasmin, α1-antitrypsin, β-glucuronidase, and total serum proteins . J Clin Endocrinol Metab 33:388-398, 1971;.
Lipsett MB, et al: Problems in contraception . Ann of Intern Med 74:251-263, 1971;.
Bingel AS, Benoit PS: Oral contraceptives: Therapeutics versus adverse reactions with an outlook for the future (pt 2) . J Pharm Sci 62:349-363, 1973;.
Beckerhoff R, et al: Plasma aldosterone during oral contraceptive therapy . Lancet 2:1218-1219, 1973;.
Skinner SL, Lumbers ER, Symonds EM: Alteration by oral contraceptives of normal menstrual changes in plasma renin activity, concentration, and substrate . Clin Sci 36:67-76, 1969;.
Carey HM: Principles of oral contraception (pt 2): Side effects of oral contraceptives . Med J Aust 2:1242-1250, 1971;.
Haller J: A review of the long-term effects of hormonal contraceptives . Contraception 1:233-251, 1970;.
Larsson-Cohn U: The two hour sulfobromphthalein retention test and the transaminase activity during oral contraceptive therapy . Am J Obstet Gynecol 98:188-193, 1967;.
Larsson-Cohn U, Stenram U: Liver ultrastructure and function in icteric and nonicteric women using oral contraceptive agents . Acta Med Scand 181:257-264, 1967;.
Beck RP, et al: Adrenocortical function studies during the normal menstrual cycle and in women receiving norethindrone with and without mestranol . Am J Obstet Gynecol 112:364-368, 1972;.
Dawkjaer-Nielsen M, Binder C, Starup J: Urinary excretion of different corticosteroid metabolites in oral contraception and pregnancy . Acta Endocrinol 60:473-485, 1969;.
Mestman JH, Anderson GV, Nelson DH: Adrenal pituitary responsiveness during therapy with an oral contraceptive . Obstet Gynecol 31:378-386, 1968;.
Bulbrook RD, et al: Effect of steroidal contraceptives on levels of plasma androgen sulphates and cortisol . Lancet 1:628-631, 1973;.
Schatz DL, Palter HC, Russell CS: Effects of oral contraceptives and pregnancy on thyroid function . Can Med Assoc J 99:882-886, 1968;.
Wynn V, Doar JWH: Some effects of oral contraceptives on carbohydrate metabolism . Lancet 2:761-765, 1969;.
Phillips N, Duffy T: One hour glucose tolerance in relation to the use of contraceptive drugs . Am J Obstet Gynecol 116:91-100, 1973;.
Davidson M, Holzman GB: Role of growth hormone in the alteration of carbohydrate metabolism induced by oral contraceptive agents . J Clin Endocrinol Metab 36:246-255, 1973;.
Hazzard WR, Spiger MJ, Bierman EL: Studies on the mechanism of hypertriglyceridemia induced by oral contraceptives , in Salhanick H, Kipnis D, VandeWiele R (eds): Metabolic Effects of Gonadal Hormones and Contraceptive Steroids . New York, Plenum Press, 1969;, pp 232-241.
Beck P: Contraceptive steroids: Modifications of carbohydrate and lipid metabolism . Metabolism 22:841-855, 1973;.
Doar JWH, Wynn V: Effects of obesity, glucocorticoid, and oral contraceptive therapy on plasma glucose and blood pyruvate levels . Br Med J 1:149-152, 1970;.
Wynn V, Doar JWH, Mills GL: Some effects of oral contraceptives on serum lipid and lipoprotein levels . Lancet 2:720-723, 1966;.
Kekki M, Nikkila EA: Plasma triglyceride turnover during use of oral contraceptives . Metabolism 20:878-889, 1971;.
Wynn V, et al: Fasting serum triglyceride, cholesterol, and lipoprotein levels during oralcontraceptive therapy . Lancet 2:756-760, 1969;.
McQueen E: Hormonal steroid contraceptives (pt 3): Adverse reactions . Drugs 2:20-44, 1971;.
Fisch I, Freedman S, Pellegrin F: Effect of oral contraceptives on the thromboelastogram . Clin Pharmacol Ther 14:238-244, 1973;.
Zuck TF, et al: Implications of depressed antithrombin III activity associated with oral contraceptives . Surg Gynecol Obstet 133:609-612, 1971;.
Hougie C: Thromboembolism and oral contraceptives . Am Heart J 85:538-545, 1973;.
Streiff RR: Folate deficiency and oral contraceptives . JAMA 214:105-108, 1970;.
Shojania AM, Hornady GJ, Barnes PH: The effect of oral contraceptives on folate metabolism . Am J Obstet Gynecol 111:782-791, 1971;.
Briggs M, Briggs M: Endocrine effects on serum vitamin B12 . Lancet 2:1037, 1972;.
Fisch IR, Freedman SH: Oral contraceptives and the red blood cell . Clin Pharmacol Ther 14:245-249, 1973;.
Koskelo P, Eisalo A, Toivonen I: Urinary excertion of porphyrin precursors and coproporphyrin in healthy females on oral contraceptives . Br Med J 1:652-654, 1966;.
Adams PW, et al: Effect of pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraception . Lancet 1:897-904, 1973;.
Jacobi JM, Powell LW, Gaffney TJ: Immunochemical quantitation of human transferrin in pregnancy and during administration of oral contraceptives. Br J Haematol 17:503-509, 1968;.
Schenker JG, Ben-Yoseph Y, Shapira E: Erythrocyte carbonic anhydrase B levels during pregnancy and use of oral contraceptives . Obstet Gynecol 39:237-240, 1972;.
Winkelman JW, et al: Estimation of norms from a controlled sample survey. II: Influence of body habitus, oral contraceptives, and other factors on values for the normal range derived from the SMA 12/60 screening group of tests . Clinical Chem 19:488-491, 1973;.
Henry JB, Krieg AF: Endocrine measurements , in Davidson I, Henry JB (eds): Clinical Diagnosis by Laboratory Methods , ed 15. Philadelphia, WB Saunders Co, 1974;, pp 745, 759.